Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
宜明昂科IMC-003/IMM72臨床試驗獲批

2025-06-23T  
宜明昂科贖回2億元理財產品 收益預期達510.2萬元

2025-06-17T  
宜明昂科委任首席醫學官

2025-06-09T  
宜明昂科IMM2510/AXN-2510聯合化療2期試驗結果預計下半年公布

2025-05-22T  
宜明昂科約1,411.4萬股已完成轉換為H股

2025-05-14T  
宜明昂科委任Weihai He為首席業務官

2025-05-06T  
宜明昂科IMC-003/IMM72臨床試驗申請獲受理

2025-04-02T  
宜明昂科董事長兼CEO增持15萬股 涉79萬元

2025-03-27T  
《業績》宜明昂科全年虧損收窄至3.16億人民幣

2025-03-26T  
宜明昂科-B收到H股全流通備案通知書

2025-03-17T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.